EPAM vs GSK · P/E 14, rev $2.81B vs P/E 13, $103.31B cap
EPAM Systems Inc (EPAM) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
GSK does not have a complete income-statement cache yet.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the EPAM and GSK stock pages for the full models.
Not investment advice.